December 19, 2022
Boston Cell Standards Gains 510(k) Clearance for Breast Cancer Test Control Panels
Continue Reading
December 19, 2022
FDA clears Boston Cell Standards’ IHControls panel in breast cancer
Continue Reading
July 11, 2022
Standardization of PD-L1 immunohistochemistry
Continue Reading
July 11, 2022
Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934
Continue Reading
April 7, 2022
Study Establishes Boston Cell Standards’ Calibrated IHC Technology for Companion Diagnostic Immunohistochemistry
Continue Reading